29 June 2021 - expansion of PathFlow Covid-19 lateral flow test portfolio
Novacyt has announced that it is to launch two PathFlow Covid-19 antigen lateral flow tests to strengthen its Covid-19 portfolio and to pursue significant new market opportunities. There is a specific focus on point-of-care settings. The company will initially target private market opportunities for the tests via its existing distribution network. The two new PathFlow Covid-19 antigen tests are convenient for use by healthcare professionals or patients in home settings. The use of point-of-care testing is a first . . .
This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.
Already a member, log in HERE.
